Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting?
Buhl Rasmussen AS, Andersen CL, Weimann A, Yang T, Tron C, Gandemer V, Dalhoff K, Rank CU, Schmiegelow K. Buhl Rasmussen AS, et al. Among authors: rank cu. Expert Rev Clin Pharmacol. 2024 Mar;17(3):225-234. doi: 10.1080/17512433.2024.2312256. Epub 2024 Feb 12. Expert Rev Clin Pharmacol. 2024. PMID: 38345044 Review.
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
Rank CU, Toft N, Tuckuviene R, Grell K, Nielsen OJ, Frandsen TL, Marquart HVH, Albertsen BK, Tedgård U, Hallböök H, Ruud E, Jarvis KB, Quist-Paulsen P, Huttunen P, Wartiovaara-Kautto U, Jónsson ÓG, Trakymiene SS, Griškevičius L, Saks K, Punab M, Schmiegelow K. Rank CU, et al. Blood. 2018 May 31;131(22):2475-2484. doi: 10.1182/blood-2018-01-827949. Epub 2018 Apr 16. Blood. 2018. PMID: 29661787 Free PMC article.
Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.
Rank CU, Wolthers BO, Grell K, Albertsen BK, Frandsen TL, Overgaard UM, Toft N, Nielsen OJ, Wehner PS, Harila-Saari A, Heyman MM, Malmros J, Abrahamsson J, Norén-Nyström U, Tomaszewska-Toporska B, Lund B, Jarvis KB, Quist-Paulsen P, Vaitkevičienė GE, Griškevičius L, Taskinen M, Wartiovaara-Kautto U, Lepik K, Punab M, Jónsson ÓG, Schmiegelow K. Rank CU, et al. J Clin Oncol. 2020 Jan 10;38(2):145-154. doi: 10.1200/JCO.19.02208. Epub 2019 Nov 26. J Clin Oncol. 2020. PMID: 31770057 Free PMC article.
Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
Jarvis KB, Nielsen RL, Gupta R, Hede FD, Huttunen P, Jónsson ÓG, Rank CU, Ranta S, Saks K, Trakymiene SS, Tuckuviene R, Tulstrup M; INVENT consortium; Ruud E, Schmiegelow K, LeBlanc M. Jarvis KB, et al. Among authors: rank cu. Thromb Res. 2020 Dec;196:15-20. doi: 10.1016/j.thromres.2020.08.015. Epub 2020 Aug 12. Thromb Res. 2020. PMID: 32818716 Free article.
Management of Asparaginase Toxicity in AYAs with ALL.
Schmiegelow K, Rank CU. Schmiegelow K, et al. Among authors: rank cu. Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S12-S13. doi: 10.1016/S2152-2650(20)30444-4. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32862850 No abstract available.
Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Toksvang LN, Andrés-Jensen L, Rank CU, Niinimäki R, Nersting J, Nielsen SN, Mogensen SS, Harila-Saari A, Abrahamsson J, Joelsson J, Overgaard UM, Quist-Paulsen P, Griškevičius L, Jónsson ÓG, Vaitkevičienė G, Frandsen TL, Toft N, Grell K, Schmiegelow K. Toksvang LN, et al. Among authors: rank cu. Cancer Chemother Pharmacol. 2021 Nov;88(5):911-917. doi: 10.1007/s00280-021-04316-z. Epub 2021 Jun 18. Cancer Chemother Pharmacol. 2021. PMID: 34145469 Clinical Trial.
22 results